Latest News in the pharma Industry

Top Stories

Ligand receives milestone payment in development of RE-021

Ligand receives milestone payment in development of RE-021

25 Feb 2013

Development of the clinical candidate RE-021 is being handled by Retrophin, which also has commercialisation rights.

Read more 
Digital Pharma Experience set for Prague

Digital Pharma Experience set for Prague

20 Feb 2013

The Digital Pharma Experience takes place in Prague in May.

Read more 
Diagnovus designs assay for DLBCL

Diagnovus designs assay for DLBCL

20 Feb 2013

Diagnovus' new gene expression assay aims to provide more accurate risk profiles for DLBCL patients.

Read more 
Roche to commercialise Chiasma’s Octreolin treatment

Roche to commercialise Chiasma’s Octreolin treatment

19 Feb 2013

Roche has acquired global licencing rights for the acromegaly treatment, which is in phase three trials.

Read more 
Almac and DSM Pharma sharing enzyme expertise

Almac and DSM Pharma sharing enzyme expertise

19 Feb 2013

The two firms are collaborating to improve their green performance and enzyme process development.

Read more 
Cancer Commons announces expansion

Cancer Commons announces expansion

14 Feb 2013

Cancer research organisation will include six new members.

Read more 
Nerve growth trial goes international

Nerve growth trial goes international

14 Feb 2013

Neurotrophic keratitis patients to get eyedrop treatment.

Read more 
Ulcerative colitis patients get new treatment

Ulcerative colitis patients get new treatment

14 Feb 2013

New treatment to help mild sufferers of ulcerative colitis.

Read more 
New contract services provided by BioMed

New contract services provided by BioMed

13 Feb 2013

BioMed has launched its new pharmacy management system RxVector.

Read more 
Heart failure treatment gets funding

Heart failure treatment gets funding

11 Feb 2013

New diagnostic tests to be developed as a result of funding.

Read more 
Microarray to be used in human identification

Microarray to be used in human identification

7 Feb 2013

Affymetrix and DNA Link team up to consumerise DNA identification technology .

Read more 
Genentech sees positive results from its CLL drug trials

Genentech sees positive results from its CLL drug trials

31 Jan 2013

Genentech has seen positive results in Phase III trials of its CLL drug.

Read more